Research Report: Oxyjun® shows promising cardiovascular health benefits
The maintenance of cardiovascular health is important for everyone, but especially for the aging population. From 1990 to 2019, Cardiovascular disease has nearly doubled. The vast majority of aging individuals with or without heart failure have demonstrated a higher oxygen demand during intense physical activity. Studies have shown that with every 10-year increase in biological age, primarily left ventricular ejection fraction (LVEF) decreases by 1%.3 This reduction may affect heart health and increase fatigue and feelings of exertion during physical activity. The recommended approach to support optimal cardiovascular health includes exercise, a healthy diet, and traditional botanicals with known heart health benefits, such as the bark of Arjuna (Terminalia arjuna).
A recent medical study showing Oxyjun® (E-OJ-01) could improve cardiac pumping capacity by significantly increasing LVEF and reducing fatigue in a diverse, healthy population from Bruce Abedon, R&D Innophos LLC, Shalini Srivastava, Clinical Development, Enovate Biolife and Robert N Girandola, Department of Human Biology, University of Southern California.
The study results show that E-OJ-01 increased the LVEF by 6.28% (percentage change) from the baseline compared with 0.24% (percentage change) in the placebo group (p< 0.05). It reduced fatigue (22.52%), RPP (1.54%), and GGT levels (5.90%) from the baseline. No adverse events related to the intervention were observed during the study.
Conclusion: The study showed that E-OJ-01 could improve cardiac pumping capacity by significantly increasing LVEF and reducing fatigue in a diverse, healthy population.
Find the research summary and report published by Journal of Multidisciplinary Healthcare on Dove Medical Press: Effect of E-OJ-01 on Left Ventricular Ejection Fraction and Myocardial Oxygen Consumption: A Randomized, Double-Blind, Placebo-Controlled Study